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In 2014, the World Health Organization (WHO) recommendation to include the endorsed
rapid molecular technologies (Xpert MTB/RIF, line probe assays) into surveillance systems
and surveys allowed the testing of more tuberculosis (TB) patients for drug resistance at
country level than ever before. The whole genome sequencing (WGS) approach is emerging
as a more powerful tool for epidemiological and drug-resistant routine surveillances,
promising a rapid and simultaneous screening of all the clinically-relevant mutations for
the determination of resistance to the first-, second-line, and new anti-TB drugs. In addi-
tion, WGS can support the conventional contact tracing for epidemiological studies with
high discriminatory power by tracking the circulating strains and their relatedness. These
features make WGS, moreso than the conventional molecular tools, an ideal tool to mon-
itor transmission and drug resistance trends in countries, providing deep and wide infor-
mation in a standardized way.
WGS technologies have already been adopted in many supranational and reference lab-
oratories at the centralized level, and several research groups are working to reduce the
complexity and costs of these platforms, from sample preparation to the downstream anal-
ysis and interpretation of sequencing reads, with the final aim to expand the use of WGS to
all laboratory levels. The landscape of the platforms available for next-generation sequenc-
ing (NGS) is rapidly enriching. It includes high-throughput instruments that can be used for
centralized surveillance studies on a large scale, and ‘‘benchtop” sequencers that con-
versely can reach more peripheral settings for rapid and non-extensive surveys.
Traditionally, WGS is performed on genomic DNA samples extracted from clinical iso-
lates to ensure the required high DNA quality and quantity for the following library prepa-
ration and sequencing reaction steps. Nevertheless, the researchers are trying to apply the
WGS to early primary cultures and in particular directly to sputum samples, including
specific procedures to remove non-mycobacterial genetic material and to enrich the
Mycobacterium tuberculosis (MTB) genome. The targeted NGS approach that takes advantage
of the amplification of selected regions of the MTB genome for genotyping and drug resis-
tance determination could represent the most effective method to avoid the need of cultur-
ing MTB prior to sequencing, also enabling the implementation of NGS for surveillance
purposes in resource-limited settings without infrastructures and equipment for growing
TB cultures.
Classical sequencing and NGS approaches have been successfully used in a recent study
conducted in five countries with high burden of TB and multidrug resistant tuberculosis. J. Myco-
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bacteriol. (2016), http://dx.doi.org/10.1016/j.ijm(MDR-TB) and aimed at investigating levels of resistance to pyrazinamide among patients
with TB by pncA sequencing [doi: 10.1016/S1473-3099(16)30190-6]. This work innovatively
demonstrated that the establishment of strong links between national (peripheral and ref-
erence laboratories) and supranational laboratories, with the former possibly processing
indirect or direct samples and generating sequencing data, and the latter supporting them
for bioinformatics analysis and data interpretation, will soon make WGS and targeted NGS
the preferred tools to conduct public health surveillances in TB field, thus helping the
strategies adopted by TB control programs at local and national levels.Conflict of interest
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